Murlikrishna Pharma Pvt Ltd

Country/Region: India     State/Province: New Delhi

Main Products: Tacrolimus, Tacrolimus

Company Introduction
Our Tacrolimus goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in NEW DELHI, , India, laced with all the required amenities to keep the Tacrolimus quality consistent and maintained. Buyers can reach us for acquiring first in class Tacrolimus, as we are enlisted among best in class Manufacturers since 2003.Entire product line from Murlikrishna Pharma Pvt Ltd Private Owner are made available in different variations with quality commitments that has no match, making our Tacrolimus and Tacrolimus highly demanded in the international market. Owing to which our export ratio value has reached US$50 Million - US$100 Million based on Australia,Canada,Germany,India,Norway market share. Being a quality-conscious entity and a leading Retailer of Tacrolimus, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 17 Years of export history led us to acquire More than 6 Million US Dollar of yearly output.Our professional enterprise was first launched with US$10 Million - US$50 Million of initial investment under Agency.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2003, 2003

Legal Status: Agency

Ownership: Private Owner

Employees: 501 - 1000 People

Factory Size: 10, 000-30, 000 square meters

R&D Team Size: 11 - 50 People

Certifications: ISO14001

Contact Information

Contact Person: rajiv

Designation: Industrial designer

Department: Owner/Entrepreneur

Telephone: 919225505043

Business Information

Main Markets: India (28%) Australia (23%) Germany (19%) Norway (12%) Canada (11%)

Export Focus: Australia, Canada, Germany, India, Norway

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: More than 6 Million US Dollar

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 11% - 20%

Payment Terms: Bank wire (T/T)

Product Showcase
Tacrolimus
Tacrolimus

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Tacrolimus in India Tacrolimus in New Delhi